Effect of selenium on the course of a postoperative period after liver transplantation
https://doi.org/10.23873/2074-0506-2009-0-2-15-18
Abstract
Objective: to study the effect of selenium on the course of a postoperative period in patients after orthotopic liver transplantation (OLT).
Subjects and methods. The prospective controlled randomized study enrolled 30 patients after OLT. Selenium (Selenase, Biosyn) was administered in Group 1 (n = 15) within 5 days operatively. The agent was not used in complex therapy in Group 2 (n = 15).
Results. After OLT, the plasma levels of selenium were much more than the normal value. In Group 1, the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly lower on day 3 after OLT and those of urea and creatinine significantly decreased by day 7. A significant difference was found in scores on day 7, as shown by the analysis of the patients' condition by the SOFA scale. The patients who needed venovenous hemodiafiltration (VVHDF) were more than in those who did not use selenium.
Conclusion. Selenium levels considerably decrease after liver transplantation. Selenase has a hepatoprotective effect, alleviates the manifestations of a systemic inflammatory response, and reduces the frequency of VVHDF use.
About the Authors
M. Sh. Khubutia
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
S. V. Zhuravel
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
A. M. Talyzin
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
V. V. Kiselev
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
Ye. R. Dorofeyeva
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
N. K. Kuznetsova
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
A. V. Chzhao
N.V. Sklifosovsky Research Institute of Emergency Care
Russian Federation
Russian Federation
References
1. Angstwurm M.W.A., Engelmann L., Zimmenmann T. et al. Selenium in Intensive Care (SIC) study: Results of a prospective randomized, placebo-controlled, multiplecenter study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007;35(1): 35—40.
2. Мухачева С.Ю., Руднов В.А., Галян С.Л., Кадочникова Т.Ю. Эффективность селена и α-токоферола в терапии больных с абдоминальным сепсисом. Инфекции в хирургии 2007;5(1):32—6.
3. Глушко А.В., Яковлева И.И., Гельфанд Б.Р. Опыт использования препарата Селеназа в комплексе интенсивной терапии больных с деструктивным панкреатитом. Инфекции в хирургии 2008;6(1):54—6.
4. Berger M.M., Eggimann P., Heyaland D.K. et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomized trials. Crit Care 2006;10:153.
5. Sakr Y. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesthesia 2007;98(6):775—84.
6. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998;5(4): 402—8.
7. Carden D., Granger D. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000;190:256—66.
8. Zapletal C., Heyne S., Breitkreutz R. The influence of selenium substration on microcirculation and glutathione metabolism after warm liver ishemia/reperfusion in a rat model. Microvasc Res 2008;76(2):1040—1.
Review
For citations:
Khubutia M.Sh., Zhuravel S.V., Talyzin A.M., Kiselev V.V., Dorofeyeva Ye.R., Kuznetsova N.K., Chzhao A.V. Effect of selenium on the course of a postoperative period after liver transplantation. Transplantologiya. The Russian Journal of Transplantation. 2009;(2):15-18. (In Russ.) https://doi.org/10.23873/2074-0506-2009-0-2-15-18
Views:
877
